ResearcherUniversity of Southern DenmarkActive in the last 2 years
Martin Graversen
Matched on ORCID iD 0000-0001-5719-4916; OpenAlex author ID A5069535705. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 4
- Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. Co-author DOI 10.1016/j.prp.2025.156250↗
- RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Co-author DOI 10.1515/pp-2024-0001↗
- Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC. First author DOI 10.1136/jclinpath-2020-206607↗
- Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Co-author DOI 10.1007/s10585-017-9849-7↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Per Pfeiffer · 4 shared papers, 2017–2025 · strength 0.70
- Paper Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. DOI 10.1016/j.prp.2025.156250↗
- Paper RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aeros… DOI 10.1515/pp-2024-0001↗
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607↗
- Michael Bau Mortensen · 4 shared papers, 2017–2025 · strength 0.70
- Paper Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. DOI 10.1016/j.prp.2025.156250↗
- Paper RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aeros… DOI 10.1515/pp-2024-0001↗
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607↗
- Sönke Detlefsen · 4 shared papers, 2017–2025 · strength 0.70
- Paper Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. DOI 10.1016/j.prp.2025.156250↗
- Paper RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aeros… DOI 10.1515/pp-2024-0001↗
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607↗
- Claus Wilki Fristrup · 3 shared papers, 2021–2025 · strength 0.61
- Paper Utility of peritoneal fluid for multiplexed mRNA profiling of peritoneal metastasis from pancreatic cancer. DOI 10.1016/j.prp.2025.156250↗
- Paper RNA expression profiling of peritoneal metastasis from pancreatic cancer treated with Pressurized Intraperitoneal Aeros… DOI 10.1515/pp-2024-0001↗
- Paper Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated… DOI 10.1136/jclinpath-2020-206607↗
- Sharuya Kulatheivam · 1 shared paper, 2025 · strength 0.25
- Malene Nielsen · 1 shared paper, 2021 · strength 0.14
- Jon Kroll Bjerregaard · 1 shared paper, 2017 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.